Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old (inclusive)
- People having surgery to remove lymph nodes from one or both armpits as part of breast cancer treatment
- People who have no signs of cancer that has spread to distant parts of the body before surgery
- People whose armpit lymph nodes may have tested either positive or negative for cancer
- People who have received chemotherapy before their surgery
- People who are willing and able to sign a written consent form
- People who are willing and able to follow all study procedures as required
Who may not be able to join:
- People who have lymphedema in the affected arm that was present from birth or developed on its own (not caused by surgery)
- People who already had lymphedema in the affected arm before the lymph node removal surgery
- People who have had radiation therapy to the armpit area before the study or surgery
- People who have had an allergic reaction to pig-derived collagen or to a dye called ICG (indocyanine green)
- People who are due to receive radiation therapy to the affected lymph node area within 4 weeks after surgery
- People who have taken part in another clinical trial or received another experimental treatment within 1 month before joining this study
- People who have another medical condition that could cause arm swelling, such as a blood clot in a vein
- People who have another medical condition that could cause symptoms similar to lymphedema in the affected arm — such as pain, swelling, or reduced arm movement
- People whose arm measurements at the start of the study show a significant size or fluid imbalance between arms (confirm with trial site for specific measurement thresholds)
- People whose life expectancy is less than 2 years for any reason
- People who are pregnant or currently breastfeeding
- People who have had issues with alcohol or substance misuse within the 6 months before joining the study
- People with a severe psychiatric (mental health) condition
- People with significant or long-term kidney problems, or who require dialysis (confirm with trial site for specific test value thresholds)
- People with significant liver problems based on blood test results at screening (confirm with trial site for specific test value thresholds)
- People with a very low white blood cell count at screening (confirm with trial site for specific threshold)
- People with a low haemoglobin (red blood cell) level at screening (confirm with trial site for specific threshold)
- People whom the trial investigators believe, for any other reason, cannot fully participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dung Nguyen, MD, PharmD, Stanford University
Phone: 6504929239
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lymphatic flow pattern of whole limb; Limb Volume; Skin thickness measurements; Bioiimpedance spectroscopy; Quality of life- Limb-Lymphedema-Specific Quality of Life (LYMQOL)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.